These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12834179)

  • 21. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nafamostat mesilate: a regional anticoagulant for hemodialysis in patients at high risk for bleeding.
    Akizawa T; Koshikawa S; Ota K; Kazama M; Mimura N; Hirasawa Y
    Nephron; 1993; 64(3):376-81. PubMed ID: 8341382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications.
    Haas S; Walenga JM; Jeske WP; Fareed J
    Semin Thromb Hemost; 1999; 25 Suppl 1():67-75. PubMed ID: 10357155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: nephrologists between two fires.
    Solak Y; Demircioglu S; Polat I; Biyik Z; Gaipov A; Acar K; Turk S
    Hemodial Int; 2013 Apr; 17(2):320-3. PubMed ID: 22631215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Beneficial characteristics of protease inhibitor as an anticoagulant for extracorporeal circulation].
    Akizawa T
    Rinsho Ketsueki; 1990 Jun; 31(6):782-6. PubMed ID: 2214168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
    Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J
    Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nafamostat mesilate on ADP-induced platelet aggregation and disaggregation in hemodialysis patients.
    Miyata M; Shirakawa T; Acharya B; Terao S; Gotoh A
    ASAIO J; 2006; 52(3):272-5. PubMed ID: 16760715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil and contact activation in simulated extracorporeal circulation.
    Sundaram S; Gikakis N; Hack CE; Niewiarowski S; Edmunds LH; Koneti Rao A; Sun L; Cooper SL; Colman RW
    Thromb Haemost; 1996 Jan; 75(1):76-82. PubMed ID: 8713783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-induced thrombocytopenia: an uncommon but serious complication of heparin use in renal replacement therapy.
    Charif R; Davenport A
    Hemodial Int; 2006 Jul; 10(3):235-40. PubMed ID: 16805883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients.
    Chang JJ; Parikh CR
    Semin Dial; 2006; 19(4):297-304. PubMed ID: 16893407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].
    Gavranić BB; Basić-Jukić N; Kes P
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulodexide for hemodialysis anticoagulation in heparin-induced thrombocytopenia type II.
    Borawski J; Zbroch E; Rydzewska-Rosolowska A; Pawlak K; Mysliwiec M
    J Nephrol; 2007; 20(3):370-2. PubMed ID: 17557272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Argatroban in adult extracorporeal membrane oxygenation.
    Johnston N; Wait M; Huber L
    J Extra Corpor Technol; 2002 Dec; 34(4):281-4. PubMed ID: 12533066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban.
    Scott LK; Grier LR; Conrad SA
    Pediatr Crit Care Med; 2006 May; 7(3):255-7. PubMed ID: 16474254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report.
    Liu W; Zhang C; Bai Q; Zhang Z
    Medicine (Baltimore); 2018 Dec; 97(50):e13609. PubMed ID: 30558037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of preoperative treatment with aspirin or heparin on platelet function and intensity of postoperative bleeding in early period after coronary artery bypass surgery].
    Veikutiene A; Sirvinskas E; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V
    Medicina (Kaunas); 2005; 41(7):577-83. PubMed ID: 16062025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study of heparin-induced thrombocytopenia].
    Wang JH; Wang CY; Xie R; Che DH; Jia RC; Ju W; Miao MJ; Wang H; Jiang Y; Tong DX
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):115-7. PubMed ID: 21429379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Delayed onset of heparin induced thrombocytopenia--a case report].
    Tahata T; Miki S; Kusuhara K; Ueda Y; Okita Y; Matsuo S
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Mar; 40(3):456-8. PubMed ID: 1583376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marked eosinophilia induced by nafamostat mesilate, an anticoagulant in a hemodialysis patient.
    Nakanishi K; Kaneko T; Yano F; Horio M; Kawagoe H; Fujii M; Kashiwai K
    Nephron; 1992; 62(1):97-9. PubMed ID: 1436301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative management of patients with heparin-induced thrombocytopenia.
    Kappa JR; Fisher CA; Todd B; Stenach N; Bell P; Campbell F; Ellison N; Addonizio VP
    Ann Thorac Surg; 1990 May; 49(5):714-22; discussion 723. PubMed ID: 1692679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.